PATENT CLAIM ANALYSIS

Application Number: 16059439
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "078320"]

Abstract:
The present invention is directed to a pharmaceutical composition comprising the compound suvorexant, or a pharmaceutically acceptable salt thereof, a concentration-enhancing polymer, and optionally a pharmaceutically acceptable surfactant.

Claim (Index 2):
The pharmaceutical composition of  claim 1 , wherein the concentration-enhancing polymer is selected from the group consisting of ionizable cellulosic polymers, nonionizable cellulosic polymers, and vinyl polymers and copolymers having substituents selected from the group consisting of hydroxy, alkyl, acyloxy, and cyclic amide.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.28
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14404147', '15305246', '14002221', '12386402', '11897940']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7652754959023903
- 35 USC 102 Novelty (BERT): 0.5385209014642249
- Combined Prediction Score: 0.7426000364585738
- Mean Citation Score: 257.12224
- Max Citation Score: 385.5299
- Similarity Product: 315.3488045297563

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test